Photrexa is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Glaukos Corporation. The primary component is Riboflavin 5'-phosphate Sodium Anhydrous.
Product ID | 25357-023_030af81d-5c28-44e7-8386-6c5b3f569af0 |
NDC | 25357-023 |
Product Type | Human Prescription Drug |
Proprietary Name | Photrexa |
Generic Name | Riboflavin 5-phosphate Ophthalmic |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2016-04-15 |
Marketing Category | NDA / NDA |
Application Number | NDA203324 |
Labeler Name | Glaukos Corporation |
Substance Name | RIBOFLAVIN 5'-PHOSPHATE SODIUM ANHYDROUS |
Active Ingredient Strength | 1 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2016-04-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203324 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-04-15 |
Ingredient | Strength |
---|---|
RIBOFLAVIN 5'-PHOSPHATE SODIUM | 1.46 mg/mL |
SPL SET ID: | f82cfe92-1a24-11e3-8ffd-0800200c9a66 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
25357-023 | Photrexa | riboflavin 5-phosphate ophthalmic |
25357-025 | Photrexa Cross-linking Kit | riboflavin 5-phosphate ophthalmic |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PHOTREXA 85849014 4724270 Live/Registered |
Avedro Inc. 2013-02-13 |